MTOR and breast cancer: In silico analysis of the proteomics findings at pathway and interactome levels revealed an activation of protein synthesis pathways (eIF2 signaling, tRNA charging, regulation of eIF4 and p70S6K signaling and mTOR signaling), which have been previously reported to be deranged in the context of BC [69–79].